Prostate cancer after castration in the elderly
Conditions
Interventions
Control group :For elderly patients with prostate cancer after castration, the control group received endocrine therapy. The control group did not take Zhi Bai Di Huang Pills or any other traditional
Experimental group:The treatment group for elderly patients with prostate cancer after castration received endocrine therapy combined with Zhi Bai Di Huang Pills
Sponsors
Lianyungang Second People's Hospital (Lianyungang Cancer Hospital)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. The biopsy confirmed the diagnosis of prostate cancer. In the 2002 American Joint Committee on Cancer prostate cancer TNM staging system, T1N0 and T2N0 stage prostate cancer was defined as localized prostate cancer. Based on the clinical data of prostate cancer patients, patients with T1-T2 stage or T2 prostate cancer with PSA > 10 ng/mL and Gleason score 60 points.
Exclusion criteria
Exclusion criteria: 1. Those with allergic constitution or who are allergic to the study drugs; 2. Those with poor compliance and unable to complete the entire observation process; 3. Those who do not exhibit the side effects of prostate cancer endocrine therapy or do not have the symptoms of liver and kidney yin deficiency as defined by traditional Chinese medicine; 4. Those with primary malignant tumors other than prostate cancer; 5. Those with severe systemic diseases such as heart, brain, liver, or kidney disorders and mental illnesses, or with a KPS score of less than 60; 6. Those with uncontrolled urinary tract infections; 7. Other situations that the researcher deems unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lumbar L2-4 orthostatic bone mineral density;Bilateral femoral neck bone mineral density; | — |
Countries
China
Contacts
Public ContactBao Qinwen
Lianyungang Second People's Hospital (Lianyungang Cancer Hospital)
Outcome results
None listed